VIRP Share Price

Open 147.20 Change Price %
High 147.75 1 Day 0.00 0.00
Low 145.70 1 Week 1.80 1.24
Close 147.00 1 Month -25.65 -14.86
Volume 4176 1 Year -12.50 -7.84
52 Week High 197.95
52 Week Low 127.00
VIRP Important Levels
Resistance 2 148.90
Resistance 1 148.12
Pivot 146.82
Support 1 145.88
Support 2 145.10
EPA France Most Active Stocks
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
GSZ 17.56 3.97%
BRS 12.00 0.00%
BRS 12.00 0.00%
EPA France Top Gainers Stocks
MLGEO 0.06 20.00%
APAM 33.78 15.72%
APAM 33.78 15.72%
MLLOI 3.80 15.15%
DEXB 17.47 13.89%
DEXB 17.47 13.89%
ALDIE 1.40 13.82%
MT 4.53 12.97%
MT 4.53 12.97%
MT 4.53 12.97%
EPA France Top Losers Stocks
MLTMT 0.01 -50.00%
MLPGO 0.11 -21.43%
MLAAE 6.48 -19.00%
MLEVE 0.09 -18.18%
TVRB 33.51 -8.84%
CGD 74.87 -5.23%
CGD 74.87 -5.23%
CGD 74.87 -5.23%
GENX 2.31 -4.94%
CGM 25.80 -4.76%

Virbac (EPA: VIRP)

VIRP Technical Analysis 4
As on 22nd Mar 2017 VIRP Share Price closed @ 147.00 and we RECOMMEND Sell for LONG-TERM with Stoploss of 161.19 & Strong Sell for SHORT-TERM with Stoploss of 167.46 we also expect STOCK to react on Following IMPORTANT LEVELS.
VIRP Target for March
1st Target up-side 173.97
2nd Target up-side 177.14
3rd Target up-side 180.31
1st Target down-side 164.93
2nd Target down-side 161.76
3rd Target down-side 158.59
VIRP Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website
VIRP Address
13e rue LID - BP 27
Carros, 06511
Phone: 33 4 92 08 71 00
Fax: 33 4 92 08 71 65
VIRP Latest News
Global Animal Antimicrobials Market 2017 Merck & Co., Inc., Bayer AG, Sanofi ...   Medgadget (blog)   - 22nd Feb 17
Virbac gives Vet Aquadent a fresh look   VetSurgeon News (press release)   - 03rd Feb 17
Virbac launches phenobarbital-based canine epilepsy treatment   VetSurgeon News (press release)   - 02nd Feb 17
Virbac : annual sales growth of 4.5%, at constant exchange rates   GlobeNewswire (press release)   - 17th Jan 17
BRIEF-Virbac says FDA lifts warning letter for St. Louis production facility   Reuters   - 12th Dec 16
Virbac launches Bovigen Scour vaccine (registration)   - 10th Feb 16
Sequent Aims to Lure Buyers in $30 Billion Veterinary Market   Bloomberg   - 30th Jul 15
New Zealand trade mark decision on FIPROLINE overturned in Court of Appeal   Lexology (registration)   - 13th Feb 15
Lilly must divest Sentinel products after FTC nod on Novartis deal   Reuters   - 22nd Dec 14
Animal health market to hit $43 billion in five years   Western Farm Press   - 30th Jul 12
Interactive Technical Analysis Chart Virbac ( VIRP EPA France )
Java support must be enabled in order to display FnCharts.
You can download Java from
Your Comments and Response on Virbac
VIRP Business Profile
Virbac SA develops, manufactures, and sells vaccines and medicines to prevent and treat pathologies for companion and food-producing animals in France, the rest of Europe, North America, Latin America, Africa, the Middle East, Asia, and the Pacific region. The company’s products comprise Bovidec to treat bovine viral diarrhea; Browse plus, a nutritional supplement; CaniLeish to protect against canine leishmaniosi; Deltanil for use in cattle and sheep as a topical application; Effi pro for flea and tick infestations in dogs and cats; Epi-Otic, a ear cleanser for dogs and cats; Flukazole C, a internal parasiticide in cattle and sheep for benzimidazole-sensitive worms; and Fortius, a injectable antibiotic. Its products also include Cydectine, a moxidectin-based parasiticide; Iverhart, a chewable tablet for use in dogs to prevent canine heartworm, roundworms, hookworms, and tapeworms; Luminal to treat epilepsy in dogs; Maxflor for respiratory diseases of bacterial origin in cattle and pigs; Milteforan, a miltefosine-based oral treatment; and Multibio for digestive, respiratory, and genitourinary diseases. In addition, the company offers Multimin, a trace element injectable supplement; Nutri plus gel, an oral paste-based food supplement; Ostovet, a food supplement for cattle; Penclox for mastitis in dairy cattle; Prodose, an anthelmintic; Pulmodox for respiratory diseases in pigs and poultry; Rabigen mono, a monovalent and multi-dose rabies vaccine; Rabigen SAG2, an oral rabies vaccine; Super Mastidol to prevent and treat mastitis in dairy cattle; Suprelorin for temporary infertility in male dogs; Virbamec, a ivermectin-based parasiticide; Vet complex, a specialised petfood; Veterin for swine, poultry, and salmonids; Vetflurane, a isoflurane-based general anaesthetic; Vimeral, a food supplement; and Zoletil, a multi-species general anaesthetic. Further, it provides contract manufacturing services. Virbac SA was founded in 1968 and is headquartered in Carros, France.